Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare oral rivaroxaban with injectable enoxaparin in
orthopaedic trauma patients to determine if orally administered rivaroxaban once daily
carries greater compliance and overall satisfaction than enoxaparin self-administered by
subcutaneous injection once daily.